Mastodawn

ABL Bio CEO Lee Sang-hoon announced at the JP Morgan Healthcare Conference that the company expects to secure new global partnerships beyond GSK, Eli Lilly, and Sanofi, following multi-trillion won licensing deals and ongoing clinical progress.
#YonhapInfomax #ABLBio #GSK #EliLilly #LicensingDeal #ClinicalProgress #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=100204

ABL Bio Expects New Partnerships Beyond GSK and Lilly

ABL Bio CEO Lee Sang-hoon announced at the JP Morgan Healthcare Conference that the company expects to secure new global partnerships beyond GSK, Eli Lilly, and Sanofi, following multi-trillion won licensing deals and ongoing clinical progress.

Yonhap Infomax

Yonhap Infomax News Dec 16

South Korea’s Adel Inc. secures a landmark $1.04 billion global licensing deal with Sanofi for its Alzheimer’s drug candidate, marking the nation’s largest biotech tech export and underscoring investor confidence in Adel’s neurodegenerative disease research.
#YonhapInfomax
#AdelInc #Sanofi #AlzheimersDrug #LicensingDeal #StonebridgeVentures
#Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=95764

Stonebridge Ventures-Backed Adel Hits $1.04 Billion Licensing Jackpot with Global Tech Export

South Korea’s Adel Inc. secures a landmark $1.04 billion global licensing deal with Sanofi for its Alzheimer’s drug candidate, marking the nation’s largest biotech tech export and underscoring investor confidence in Adel’s neurodegenerative disease research.

Yonhap Infomax

Yonhap Infomax News Nov 4

Celltrion has signed an exclusive licensing deal with US biotech Kaigene, securing two antibody-based drug candidates for autoimmune diseases in a deal worth up to 1.062 trillion won ($770 million), further strengthening its position in innovative drug development.
#YonhapInfomax #Celltrion #Kaigene #AntibodyTherapeutics #AutoimmuneDisease #LicensingDeal #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=89053

Celltrion Secures Two Antibody-Based Drug Candidates Through Exclusive Licensing Deal With US Biotech

Celltrion has signed an exclusive licensing deal with US biotech Kaigene, securing two antibody-based drug candidates for autoimmune diseases in a deal worth up to 1.062 trillion won ($770 million), further strengthening its position in innovative drug development.

Yonhap Infomax

PPC Land Oct 30

Udio settles copyright lawsuit, partners with Universal Music Group: Udio disables downloads as part of licensing deal with Universal Music Group, settling copyright infringement litigation through industry-first agreements. https://ppc.land/udio-settles-copyright-lawsuit-partners-with-universal-music-group/ #Udio #CopyrightLawsuit #UniversalMusicGroup #MusicIndustry #LicensingDeal

Udio settles copyright lawsuit, partners with Universal Music Group

Udio disables downloads as part of licensing deal with Universal Music Group, settling copyright infringement litigation through industry-first agreements.

PPC Land

IndieAuthors.Social News Jul 10, 2025

News Summary: Sarah J. Maas Signs Licensing Deal with IMG to Expand ACOTAR Universe Beyond Books

Thanks, as they so often do, go to Mark Williams for alerting me to a story I had missed about Sarah J. Maas. Unusually so, because I have spent a considerable part of this year writing about romantasy, a genre that Maas has arguably done more…
https://selfpublishingadvice.org/sarah-j-maas/

#ACOTARuniverse #bookmerchandise #IMGpartnership #licensingdeal #romantasygenre
@indieauthors